XOMAP
XOMA Royalty CorpPrice
Daily candles with volume.
Signal stack
Where each data set points today.
- Short sellersCOVERING
Short interest −50.4% to 276 shares. 1.0 days to cover, ≈0.0% of shares.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Next FY | None | None | No data | $0.00 |
| Current Q | None | None | No data | $16.1M |
| Current FY | None | None | No data | $65.0M |
| Next Q | None | None | No data | $16.4M |
Short side
FINRA· Jun 30, 2026| Jul 13, 2026 | Deletion | Resumed |
SecBot reports
6 filings · 4 bullish · 0 bearish · 2 neutral- BULLISH DEFM14AJun 10, 2026
XOMA Royalty filed its definitive proxy statement on Schedule 14A, setting a special stockholder…
The deal is largely locked in with >44% of votes already committed. The key variable for XOMAP holders is the pre-closing redemption of the perpetual preferred at par plus accrued dividends, which…
- BULLISH 425May 26, 2026
XOMA Royalty filed its preliminary proxy statement/prospectus on Form S-4 with the SEC in…
The filing confirms deal progression with no adverse changes. The key catalyst is the stockholder vote, which is virtually assured given BVF's 43.3% support. Monitor for HSR clearance and any…
- NEUTRAL DEFA14AMay 18, 2026
XOMA Royalty Corp filed a DEFA14A (definitive additional proxy soliciting material) disclosing…
This is a procedural amendment that does not change the deal economics. Monitor for the definitive proxy statement filing, which will contain the shareholder vote date and management's…
- BULLISH DEFA14AApr 27, 2026
XOMA Royalty Corporation has agreed to be acquired by Ligand Pharmaceuticals for $39.00 per share…
Monitor the shareholder vote scheduled for the Company Stockholders Meeting and track regulatory approval progress, as these are key milestones for deal completion.
All XOMAP filing & press-release reports (6)
- DEFM14A reportJun 10, 2026
- 425 reportMay 26, 2026
- DEFA14A reportMay 18, 2026
- DEFA14A reportApr 27, 2026
- 8-K reportApr 27, 2026
- DEFA14A reportMar 30, 2026